Role of Dietary Nutrients in the Modulation of Gut Microbiota: A Narrative Review.
Yang Q, Liang Q, Balakrishnan B, Belobrajdic DP, Feng QJ, Zhang W. · 2020
Read Role of Dietary Nutrients in the Modulation of Gut Microbiota: A Narrative Review. by Yang Q, Liang Q, Balakrishnan B, Belobrajdic DP, Feng QJ, Zhang W. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7071260.txt.
Introduction
Yang and co-authors review how diet shapes gut microbes in the journal Nutrients. Knowing which nutrients feed which bacteria could guide foods and eating patterns against the global burden of non-communicable disease. The authors assessed studies published from 2005 to 2019 that tested micro- and macronutrients on the gut microbiome, in test tubes, animals, and human trials.
For micronutrients the human evidence is thin, though polyphenols from red wine and tea and vitamin D look promising in preclinical work. Fibre shows the most consistent clinical support: arabinoxylans, galacto-oligosaccharides, inulin, and oligofructose all promote beneficial bacteria and suppress harmful ones. The amount and type of dietary fat shift the microbial balance both ways, and protein quantity and source have substantial, differing effects. The authors call for more clinical work tying nutrients to the microbiome and its chemical output, and from there to host health.
Catalog record
| CREATOR | Yang Q, Liang Q, Balakrishnan B, Belobrajdic DP, Feng QJ, Zhang W. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 140 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Role of Dietary Nutrients in the Modulation of Gut Microbiota: A Narrative Review By Qi Yang, Qi Liang, Biju Balakrishnan, Damien P Belobrajdic, Qian-Jin Feng, Wei Zhang Published in: Nutrients DOI: 10.3390/nu12020381 ABSTRACT Abstract Understanding how dietary nutrients modulate the gut microbiome is of great interest for the development of food products and eating patterns for combatting the global burden of non-communicable diseases. In this narrative review we assess scientific studies published from 2005 to 2019 that evaluated the effect of micro- and macro-nutrients on the composition of the gut microbiome using in vitro and in vivo models, and human clinical trials. The clinical evidence for micronutrients is less clear and generally lacking. However, preclinical evidence suggests that red wine- and tea-derived polyphenols and vitamin D can modulate potentially beneficial bacteria. Current research shows consistent clinical evidence that dietary fibers, including arabinoxylans, galacto-oligosaccharides, inulin, and oligofructose, promote a range of beneficial bacteria and suppress potentially detrimental species. The preclinical evidence suggests that both the quantity and type of fat modulate both beneficial and potentially detrimental microbes, as well as the Firmicutes/Bacteroides ratio in the gut. Clinical and preclinical studies suggest that the type and amount of proteins in the diet has substantial and differential effects on the gut microbiota. Further clinical investigation of the effect of micronutrients and macronutrients on the microbiome and metabolome is warranted, along with understanding how this influences host health. Keywords: micronutrient, macronutrient, gut, microbiome, nutrition, health, diet, review 1. INTRODUCTION Over the past two decades a plethora of studies have identified broad-spanning associated links between the gut microbiota and systemic health and disease risk [1,2,3]. Earlier, it was estimated that the human body harbors about 1014–1015 microbial cells [4,5,6], which is thought to outnumber host cells in the human body by a ratio of at least 10:1 [7]. This was refuted recently, with an estimate that the ratio is much closer to 1:1 [6]. Importantly, the human microbiome is far more diverse than that of human cells, which adds to the complexity in trying to understand how the microbes and their metabolites effect health and modulate the development of disease [8]. This challenged the researchers to explore the roles of the human microbiota and their potential applications in managing human health and disease conditions. The large intestine is the predominant location where microbes are present in the human gut and our understanding of the composition, interaction, and functions of these gut microbes [9] continues to develop as a result of advancement in major initiatives that have categorized the microbiome [1,10,11,12,13]. The human gut microbiome is highly dynamic during the various stages of human development and has been implicated in a variety of health and disease conditions. There are many factors that contribute to shaping the gut microbial colonization, growth, composition, and diversity. The major factors that impact microbial colonization and diversity include age [14], genetics [15,16,17], mode of delivery at birth [18,19], method of feeding in infants [20,21], medications (e.g., antibiotics), [22,23] geographical location [24], and the diet [25]. Metagenomics studies in a Dutch population have shown associations between gut microbiota and 126 exogenous factors, 31 intrinsic factors, 12 diseases, 19 drug groups, 4 smoking categories, and 60 dietary factors [26]. The responses of the gut microbiota to sensitive factors are considered to be a valuable tool to exploit and develop new strategies to promote human health. Among these influential factors, dietary factors, including micro- and macro-nutrients, are the most influential in shaping and modulating the human gut microbiota [27]. Interactions between the intestinal microbiota and the host are crucial to understand the role of the microbiota in biological processes, and how they contribute to health and the development of disease. Microbial diversity measures the distribution of different species on the community, the level of which is reduced during gut dysbiosis, and a richness of species indicates a “healthy gut” [28,29,30]. Lower bacterial diversity was reported in people suffering from inflammatory bowel disease, Type 2 diabetes (T2DM), and Coeliac disease. Recent studies have identified the dominance of some groups of gut microbes that are associated with a good health outcome [28,29,30], and these microbes are presented in this review as “potential beneficial microbes”, that include major species from the genera Bifidobacterium, Lactobacillus, Akkermansia, Fecalibacterium, Eubacterium, Roseburia, Ruminococcus, and Blautia. Studies have also reported the abundance of specific bacteria that could potentially contribute to the development or progression of major non-communicable diseases and these microbes are presented in this review as “potential detrimental microbes”, that include some species from the genera Clostridium, Enterobacter, Enterococcus, Bacteoidetes, and Ruminococcus [31,32,33]. Both human and animal studies report that an increase in the Firmicutes to Bacteroidetes ratio (F/B ratio) is associated with obese/lean phenotypes and may modulate energy balance [34,35]. The aim of this narrative review was to assess scientific studies that evaluated the effect of micro- and macro-nutrients on the composition of the gut microbiome using in vitro and in vivo models, and human clinical trials. Scientific studies published between 2005 and 2019 in the databases of PubMed, Scopus, and Web of Science were identified using specific search terms (Supplementary Table S1). Publications that did not specifically quantify changes in gut microbiota were excluded, resulting in a total of 213 articles that were selected for preparing this review. The major findings relating to the microbiome, including the shifts in potentially beneficial and detrimental gut microbiota, the F/B ratio, and microbial diversity, are discussed in this review. The studies reviewed included in vitro and in vivo models and human clinical trials (in that order whenever available) and were separated based on micro- and macro-nutrients. 2. ROLE OF DIETARY MICRONUTRIENTS IN MODULATING GUT MICROBIOTA 2.1. Polyphenols Polyphenols, such as flavonoids, phenolic acids, stilbenes, and lignans [36] from fruits, vegetables, cereals, tea, coffee, and wine [37], have attracted research interest due to their potential anti-oxidative, anti-inflammatory, and anti-carcinogenic effects [38]. In vitro studies suggest that polyphenols could modulate human gut microbiota by inhibiting potential pathogenic organisms (such as Helicobacter pylori, Staphylococcus sp.) and favoring the growth of potential beneficial members, including Lactobacillus and Bifidobacteria [39,40]. Animal and clinical trials show that polyphenols can modulate gut microbes, microbial diversity, and the ratio of Firmicutes to Bacteroidetes (F/B) [41,42,43,44]. These and other studies have suggested that the prebiotic-like activities of polyphenols are the major reason behind the health benefits imparted by polyphenols in humans [45]. Herein, we discuss in vitro, animal, and clinical trial data that evaluated the effect of polyphenols on gut microbes, microbial diversity, and F/B ratio, and the major findings are summarized in Table 1. [Table: Modulations of dietary polyphenols on potentially beneficial and detrimental gut microbiota.] In vitro studies have shown that flavonoids such as anthocyanins, phenolic acids (epicatechins, p-coumaric acid, and o-coumaric acid), and other polyphenols like quercetin, rutin, chlorogenic acid, and caffeic acid could increase the abundance of beneficial gut microbiota, such as Bifidobacterium and Lactobacillus, and decrease the number of potential pathogenic bacterial colonization in the human gut [39,40,46,47]. Catechins have also been shown to stimulate the growth of the Clostridium coccoides-Eubacterium rectale group, Bifidobacterium sp., and Escherichia coli and inhibit the growth of a potential pathogenic organism (Clostridium hystolyticum group) [48]. Fermentation of polyphenols increases the